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Summary 
Natural killer (NK) cells are heterogeneous in their specificity and expression of cell surface mole- 
cules. In the mouse, the Ly-49A molecule is a primary determinant of NK cell specificity because 
of its ability to downregulate NK cell activation after physical interaction with target cell MHC 
class I molecules. Ly-49A is expressed on an NK cell subset, and it belongs to a family of highly 
related molecules that may similarly dictate major histocompatibility complex (MHC) class I- 
associated  specificity of Ly-49A- NK ceUs. It is not known, however, whether murine NK cell 
specificity may occur independently of the Ly-49 family and target cell MHC class I molecules. 
Similar to the impact of cloned murine T cell lines on molecular description of T cell recogni- 
tion, derivation of cloned murine NK cells should permit dissection of NK cell specificity but, 
to date, it has not been possible  to produce such effector cells.  In this study, we derived NK 
cell clones from mice that were homozygous for a mutation in the p53 tumor suppressor gene. 
The cloned cells displayed the molecular, cell surface,  and functional phenotype of NK cells. 
Significantly, the NK cell clones displayed clonal differences in ability to kill a panel of murine 
tumor targets and did not lyse normal cells.  Target lysis was unaffected by target cell MHC 
class I expression, and none of the clones expressed Ly-49A on the cell surface or transcripts 
for Ly-49 isoforms. Although consistent with the possibility that NK cell specificity for MHC 
class I molecules is mediated by the Ly-49 family of molecules, the results indicate that NK cell 
specificity also is regulated by a mechanism independent of target cell MHC class I and the Ly-49 
family. 
N 
'K cells represent an important population of lympho- 
cytes involved in cellular host defense. NK cells can 
recognize and destroy transformed cells  and cells  infected 
with intracellular pathogens but they generally spare  nor- 
mal cells (1, 2). NK cells are distinguishable from cytotoxic 
T  cells because they do not express the TCR.  Although 
NK cells may express  CD8  and the ~" chain of the TCR/ 
CD3 complex on the plasma membrane, as well as other CD3 
components in the cytoplasm, they do not rearrange TCR 
genes and do not express full-length TCR transcripts (3-7). 
In contrast to CD8 §  MHC class I-restricted T  cells,  NK 
cells do not require expression of MHC class I on targets 
for lysis (2). Instead, MHC class I molecules actually protect 
targets from natural killing, and certain MHC class I mole- 
cules are more protective than others (8-11),  suggesting that 
NK cells may possess inhibitory MHC class I-specific receptors 
that influence their specificity. 
Although functional studies traditionally have been done 
with bulk populations of NK cells, recent studies have clearly 
demonstrated that NK cells are heterogeneous with respect 
to their cell surface molecules that determine their specificity 
for target MHC class I.  In humans, the expression of p58 
molecules correlates with MHC specificity of NK cell clones 
(12). mAb blocking and MHC class I transfection of targets 
strongly  suggest  that  p58  molecules  determine  NK  cell 
specificity by engaging certain MHC class I molecules. Similar 
analysis suggests a role for the NKB1 and Kp43 molecules 
in human NK cell specificity (13, 14). In the mouse, we pre- 
viously determined that the mouse cell surface Ly-49A mole- 
cule, expressed on 15-20% of C57BL NK cells, is a primary 
determinant of NK cell specificity (15). Cell binding experi- 
ments indicate that Ly-49A is capable of physically interacting 
with H-2D a or H-2D k (16, 17). Functional studies strongly 
suggest that this interaction leads to "negative" signals that 
globally inhibit cytolytic activity of Ly-49A § NK cells (15). 
In support of the influential role of this interaction on NK 
cell activation, Ly-49A belongs to a family of highly related 
molecules that are encoded by cross-hybridizing genes, which 
may be expressed by Ly-49A- NK cells (18, 19). These mol- 
ecules, like Ly-49A, may be heterogeneously expressed by over- 
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molecules indicate that  these molecules are encoded by Ly- 
49C and Ly-49G, respectively, consistent with this possibility 
(20, 21). Thus, the Ly-49 family, like Ly-49A, may influence 
mouse NK cell specificity for MHC class  I  molecules. 
There may be another level of specificity,  however, because 
MHC class I molecules do not account for all aspects of sus- 
ceptibility to natural killing. For example, in our initial anal- 
ysis  of NK  cell subsets,  most but  not  all  H-2  a haplotype 
targets  were killed  efficiently by Ly-49A-  NK  cells,  sug- 
gesting that another mechanism was involved in recognition 
of these resistant targets (15). Analogous to the Ly-49A/H- 
2D  d paradigm,  this may be caused by inhibition of NK cell 
function by engagement of other Ly-49 family members on 
NK cells  with  their presumed MHC class  I molecules on 
the target.  Alternatively,  the mechanism could be indepen- 
dent of the Ly-49 family and target MHC class I molecules, 
perhaps because of the specificity of another NK cell receptor 
that directly activates natural  killing.  The latter possibility 
suggests a higher  order level of complexity in  mouse NK 
cell specificity than is currently appreciated and is compat- 
ible with  a two-receptor model for NK cell specificity in- 
volving inhibitory MHC class I-specific receptors that regu- 
late activation  receptors (22). 
To address the possible mechanisms involved in NK cell 
specificity,  it is necessary to reduce the polyclonal heteroge- 
neous specificity of bulk NK cells to a monoclonal level by 
derivation of cloned NK cell lines. Indeed, significant advances 
have been possible with  analysis  of human  NK cell clones 
(12-14). Derivation of mouse NK clones may provide similar 
insight and complement the human studies. Despite vigorous 
initial proliferation in vitro, however, it was not previously 
possible to generate murine NK cell lines because NK cells 
eventually undergo a senescent process (Karlhofer,  F. M., and 
W. M. Yokoyama, unpublished observations).  The recent avail- 
ability of mice homozygous for a targeted deficiency in the 
p53 tumor  suppressor gene (p53-/-) 1 provided a means to 
solve this technical obstacle (23). Fibroblasts, explanted from 
p53 -/-  mice,  were capable of long-term  growth  in  vitro, 
maintained  the  morphology  and  functional  phenotype  of 
normal cells, and they did not undergo senescence (24, 25). 
Yet these cells were not  transformed  and did not produce 
tumors when transplanted into athymic hosts,  suggesting that 
specific stimulation of NK cells from the p53-deficient mice 
may result in derivation of long-term cloned NK cell lines. 
In this study, we stimulated proliferation of NK cells iso- 
lated from p53-/-  mice, and we obtained long-term cloned 
NKI.1 § CD3-  cell lines  with the molecular and functional 
features of NK cells.  The cells  displayed clonal differences 
in their ability to lyse a panel of murine tumor targets.  Yet 
these cells did not express transcripts for the cross-hybridizing 
Ly-49 family of molecules, and they did not exhibit specificity 
1Abbreviations used in  this paper: 32m -/- , 32-microglobulin deficient; 
GAPD, glyceraldehyde-3-phosphate  dehydrogenase; p53-/-, p53-deficient; 
rhlL-2, recombinant human IL-2; RxMIg, rat anti-mouse Ig. 
that was influenced by expression of target cell MHC class 
I molecules. These data demonstrate that an Ly-49-indepen- 
dent mechanism also determines specificity of NK cells for 
their  targets. 
Materials and Methods 
Mice.  C57BL/6J mice were obtained from Jackson Laboratory 
(Bar Harbor, ME). The homozygous p53-deficient (p53 -/-) strain 
and homozygous/32-microglobulin-deficient (B2m  -/-) strain, each 
back-crossed to C57BL/6 four times (Cruz, T., personal commu- 
nication),  have been described (23, 26) and were obtained from 
GenPharm  International  (Mountain  View, CA). 
Cell Lines.  The following murine tumor cell lines used in this 
study were obtained from The American Type Culture Collection 
(ATCC, Rockville, MD) and maintained in our laboratory: EL-4 
(C57BL/6N-derived  T cell lymphoma),  CTL-L, (IL-2-dependent 
C57BL/6-derived  T  cell), YAC-1 (Moloney  virus-transformed 
A/Sn-derived T cell lymphoma), BW5147 (AKR-derived T cell), 
LB27.4 (B cell hybridoma), L5178Y-R (DBA/2-derived thymoma), 
P388D1 (DBA/2-derived  macrophage),  WEHI 265.1 (BALB/c- 
derived macrophage), R1.1 and 32m- variant RIE/T18x.1  (C58- 
derived thymomas), and C1498 (C57BL/6-derived leukemia). The 
C1498 cell lines, C1498D12, C1498K13, and C1498L8, transfected 
with D a, K  a, or L  a, respectively, have been described previously 
(15). The RMA cell line (C57BL/6-derived  lymphoma) and the 
Tap-2-deficient mutant RMA-S (27) were provided by Dr.  Klas 
K~rre (Karolinska Institute,  Stockholm,  Sweden). 
Antibodies.  The hybridomas producing  mAb PK136 (mouse 
anti-NKl.1), AF6-88.5.3 (mouse anti-Kb), 53-6.72 (rat anti-CDS), 
GK1.5 (rat anti-CD4),  2.4G2 (rat anti-FcqcRII/lll),  MAR 18.5 
(anti-rat r), and 145-2Cll (hamster anti-CD3e) were obtained from 
ATCC. Affinity purified rabbit anti-mouse Ig (RxM Ig) and FITC- 
conjugated  RxM  Ig  were  obtained  from  Cappel  Laboratories 
(Cochranville, PA). Affinity-purified mAb MAR-18.5  was con- 
jugated to FITC according to standard procedures. Ascites prepa- 
rations of antibodies were used unless indicated otherwise, and the 
specific titer was determined by flow cytometry analysis. Saturating 
concentrations of the mAb were always detectable at dilutions of 
~<0.25%. 
Media and Reagents.  Recombinant human IL-2 (rhIL-2; Chiton, 
Emeryville, CA) was titered by IL-2 bioassay with CTLL cells. 
All cultures  were performed  in complete medium  consisting of 
RPMI-1640 (GIBCO BRL, Gaithersburg, MD) supplemented with 
L-glutamine (300/.tg/ml), penicillin (100 U/ml), streptomycin (100 
/zg/ml),  2-ME  (5  x  10 -s  M),  and  10%  heat  inactivated FCS 
(GIBCO BRL). 
Generation of NK Clones Derived  from p53-deficient Mice.  Freshly 
isolated NK cells were prepared as described (28). Briefly, spleen 
cell suspensions were prepared from C57BL/6J or p53 -/-  mice 
and RBCs were lysed with 0.14 M NH4C1, 0.017 M Tris, pH 7, 
and washed (HBSS plus 10% FCS). Single-cell suspensions were 
incubated on a nylon wool column for 1 h. Nylon wool-nonad- 
herent cells were incubated with mAbs 53-6.72 and mAb GK1.5 
(0.5%  ascites preparation)  on ice in HBSS plus 3% FCS for 30 
min,  washed,  and incubated  with affinity-purified RxM Ig (10 
/xg/ml) and rabbit complement (Low-Tox-M;  Cedarlane, Westbury, 
NY) for 45 min at 37~  Surviving cells were isolated by centrifu- 
gation on a density gradient (Lympholyte-M; Cedarlane) at 1,000 g 
for 30 min  at room temperature,  harvested from the interface, 
washed, and used for flow cytometry and culture experiments. Rou- 
tinely, 75-80% of these cells expressed the NKI.1 antigen as deter- 
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with mAb PK136 or mAb AF6-885.3 (0.5% ascites preparation 
in RPMI) overnight at room temperature and washed three times 
with HBSS plus 3% FCS. Cells were cultured (2.5  x  10S/ml) in 
complete medium containing rhlL-2 50 U/ml in 24- or 96-well flat- 
bottom plates (previously coated with mAb) for 5 d. Proliferating 
cells from anti-NKl.l-coated wells were harvested on day 6 and 
analyzed by flow cytometry. These cells from both C57BL/6J and 
p53 -/- mice had the phenotype of NK cells. Almost all cells ex- 
pressed the NKI.1 antigen and Fc3'RII/III but were CD3-. The 
cells were seeded at various densities (5  x  103 to 5  x  10  s cells/ml) 
in complete medium supplemented with rhlL-2  (50 U/ml) with 
or without immobilized anti-NKl.1 mAb. On day 36, cells from 
individual wells were harvested and subjected to cloning by lim- 
iting dilution in 96-well round-bottom plates with rhlL-2 (50 U/ml), 
20%  FCS,  and feeder cells. The feeder cells were derived from 
C57BL/6J spleen, washed, depleted of red blood cells, and incubated 
with mitomycin-C (25/~g/ml) at 107 cells/ml for 20 min at 37~ 
Cells were washed five times, and 105 cells were added to cloning 
wells. With anti-NKl.1 restimulation, 46 growing clones were ini- 
tially derived from 288 wells seeded at 10 cells per well. Although 
no clones grew from wells seeded at 1 cell per well, the efficiency 
of growth (16~  suggests monoclonality. This was verified by the 
different killing profiles of the derived clones (see Results). Three 
clones (KY-1, KY-2, and KY-3) grew vigorously and were studied 
further. From cloning of cells that were not restimulated with anti- 
NKI.1, 24 lines were derived from 384 wells seeded at 100 cells 
per well, but only one (KY-4) could be derived by further sub- 
cloning under more stringent conditions (1 cell per well). Attempts 
to generate NK clones from C57BL/6J wt mice under similar con- 
ditions were repeatedly unsuccessful. 
DNA Probes.  The following DNA probes (kindly provided by 
Dr. David Cohen, National Institutes of Health, Bethesda,  MD) 
were used  to  detect TCR  gene rearrangement  and  expression: 
TCR-c~: 690-bp Avail fragment containing most of V~x, Jet, Ccr 
(clone TTll [29]);  TCR-/$: 660-bp EcoRI fragment containing 
D31, J~1.3, C~1 (clone 86T5 [30]); C'yl: ~o600-bp EcoRI frag- 
ment containing the second half of the CI exon, exons CII and 
CIII, and  ~120 bp of 3' untranslated region (clone pC3,1  [31]); 
Cy4: 418-bp AvalI fragment containing complete Cy4 cDNA (clone 
p'y4.2 [32]); TCR-~: ~600-bp EcoRI fragment containing C~J~ 
(Cohen, D., unpublished observation; clone T1958 [33]). The fol- 
lowing probes were also used: p53 gene: 950-bp XhoI/SaclI frag- 
ment of pMSVcL (34) (kindly provided by Dr. James Manfredi, 
Mt.  Sinai Medical  Center, New York,  NY); Ly-49: 639-bp PstI 
fragment or a 1,071-bp XhoI/HindlII fragment of pal.3 containing 
the Ly-49A cDNA (35); NKR-PI: 912-bp EcoRI/XhoI fragment 
of MusNKR-PIC cDNA (36); and glyceraldehyde-3-phosphate  de- 
hydrogenase (GAPD):  780-bp  PstI/XbaI  fragment of pHcGAP 
containing human GAPD cDNA  (37)  (kindly provided by Dr. 
F. Ramirez, Mt.  Sinai Medical Center). 
Southern Blot Analysis.  Genomic DNA from mouse liver and 
various cell lines was isolated as described (38). Briefly, frozen pow- 
dered tissue was incubated in extraction buffer (0.01 M Tris, 0.1 
M EDTA, 20 #g/ml pancreatic RNase, 100 #g/ml proteinase K) 
for 3 h at 50~  DNA was phenol extracted twice and then eth- 
anol precipitated. Redissolved  DNA (10 #g) was subjected  to re- 
striction enzyme digestion, electrophoresed on a 0.8% agarose gel, 
transferred to nylon membranes (Schleicher & Schuell, Inc., Keene, 
NH), immobilized by baking, prehybridized,  and hybridized to var- 
ious  32p-radiolabeled DNA  probes  labeled  by random  hexamer 
priming as described previously (39). The membranes were washed 
in 0.2x  SSPE (1  x  SSPE =  0.15 M  NaC1,  0.01  M NaH2PO4, 
0.01 M EDTA), 0.2% SDS for 30 min at 55~  and dried. Blots 
were exposed to x-ray film for from 2 d to 3 wk at  -80~  (In 
some experiments, a photograph of the original autoradiograph 
was cut and pasted to reorder the lanes. This was done to preserve 
lane order between figures.  This did not alter the results of the 
experiments. In no case were figures spliced from more than one 
autoradiograph.) 
Northern Blot Analysis.  Briefly, polyadenylated RNA was iso- 
lated from cell lines using an RNA isolation kit (Fast Track; In- 
vitrogen, San Diego, CA). 1-2 #g of RNA was analyzed per lane 
on a denaturing 1% agarose/formaldehyde gel,  as previously de- 
scribed (18), and further processed as described above. For loading 
controls, the membranes were stripped and rehybridized with a 
cDNA probe for human GAPD. 
Flow Cytometry Analysis.  The cells were stained with saturating 
concentrations of mAbs as previously described (40) and analyzed 
on a FACScan  |  (Becton Dickinson & Co., Sunnyvale, CA). Dead 
cells were excluded by propidium iodine staining,  and debris was 
excluded by light scatter parameters.  Routinely, 104 events were 
collected on a live gate. 
NK  Cell Cytotoxicity.  51Cr release  cytotoxicity experiments 
were performed as described previously (15). Percent specific cyto- 
toxicity was calculated  according to a standard formula (15). 
Generation of Con A-activated Blast Target Cells.  After RBC lysis 
as described  above, spleen cells from/~2m -/-  or C57BL/6J mice 
were cultured for 48 h with 5/zg/ml Con A (Pharmacia  Inc., Pis- 
cataway, NJ) and 50 U/ml rhlL-2.  Cells were harvested and live 
cells were separated by density gradient centrifugation (Lympho- 
lyte-M; Cedarlane).  Washed cells were labeled with SlCr and used 
as targets in a cytotoxicity assay. 
Results 
Generation of Long-term Cloned Cell Lines from p53-deficient 
Mouse NK Cells.  The NKI.1  antigen  (MusNKR-P1C)  is 
the most specific serological marker of routine NK cells (5). 
Anti-NKR-P1 mAbs can specifically trigger NK cell lysis of 
otherwise resistant  targets  and biochemical signals  seen in 
natural killing (28,  41,  42).  Similar to anti-CD3  antibody 
stimulation of T  cells, therefore, we found that freshly iso- 
lated NK cells proliferate in response to anti-NK 1.1 and low 
doses of IL-2 (Reichlin, A., F. M. Karlhofer, and W. M. Yo- 
koyama, manuscript in preparation). However, after vigorous 
growth for 7-10 d, anti-NKl.l-stimulated NK cells, like NK 
cells activated by high concentrations of IL-2 (800 U/ml), 
entered a senescent phase, refractory to further stimulation, 
and they underwent morphological changes consistent with 
apoptosis (Karlhofer, F. M., and W. M. Yokoyama, unpub- 
lished observation). In contrast to normal cells, anti-NKl.1- 
stimulated p53-/-  cells could be maintained in culture and 
cloned by limiting dilution.  Repeated anti-NKl.1  stimula- 
tion, however, was not required for in vitro propagation of 
the established clones (data not shown).  These clones have 
demonstrated stable proliferation for almost 1 yr in continuous 
culture,  permitting  detailed analysis. 
The Cloned Cell Lines Carry the p53 Mutation.  The wt p53 
gene can be distinguished from the disrupted gene by altera- 
tion of a 16-kb EcoRI fragment to novel fragments (8 and 
8.5 kb) caused by an EcoRI site in the targeting vector (23). 
The disrupted p53 gene was readily detectable in DNA iso- 
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10/.tg genomic DNA from (lane I ) C57BL/6J liver, (lane 2) Ly-49- IL- 
2-activated NK cells, (lane 3) KY-1, (lane 4) KY-2, (lane 5) KY-3, (lane 
6) KY-4,  (lane  7) EL-4, (lane  8)  CTL-L,  or (lane 9) p53 -/-  liver was 
digested with EcoRI, electrophoresed,  blotted to nylon membranes,  and 
hybridized with 3zp-labeled p53 probe.  HindllI-digested XDNA served 
as molecular weight markers and are indicated in kilobases. 
lated from the NK clones, whereas the wt p53 gene was present 
in DNA from control cell lines and C57BL/6 mice (Fig. 1). 
Thus, the isolated  clones are homozygous for the targeted 
mutation in the p53 gene. 
Phenotype of  p53-deficient Cloned Cell Lines.  The four clones 
were selected on the basis of growth and uniform expression 
of NK cell-specific  molecules. They expressed the NKI.1 
(NKR-P1C) molecule on the surface at levels comparable to 
freshly  isolated  NK  cells  (Fig.  2).  Consistent with  this, 
Northern blot analysis revealed three characteristic bands of 
NKR-P1 transcripts as previously described (43) (Fig. 3). By 
flow cytometry, the NK cell clones expressed FcyRII/III but 
lacked surface expression  of CD3e (Fig.  2), TCR-ot/~,  or 
TCR-T/~ (data not shown). Except for the KY-2 clone that 
expressed low levels of CD8, the clones were initially nega- 
tive for CD4 and CD8 surface expression (data not shown). 
Other expressed molecules included Thy-1  and the activa- 
tion markers CD69 and Lyo6 (data not shown), as described 
for IL-2-activated NK cells (28). The clones continued to re- 
quire Ib2 at intermediate concentrations  (~50 U/ml) for op- 
timal growth and showed variable expression of the IL-2Rot 
chain (p55) by antibody staining (data  not shown). These 
data demonstrate that these cloned cell lines displayed the 
surface phenotype of murine NK cells. 
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Figure  2.  Flow cytometric analysis of p53-deficient  clones. The NK clones KY-1 (a, e, and i), KY-2 (b,f, and j) KY-3 (c, g, and k) and KY-4 (d, 
h, and I) were incubated with mAbs specific for NKI.1 (a-d),  CD3e (e-h),  or Fc3'RIl/IlI (i-l)  and then with a FITC-conjugated rabbit anti-mouse 
Ig (a-h) or FITC-conjugated MAR 18.5 (i-l).  Specific staining (solid lines) and staining with FITC-conjugated second-step reagent alone (dashed lines) 
are shown.  Histograms of unstained cells were identical to those obtained when cells were incubated with second-step  reagent  alone (not shown). 
Rabbit anti-mouse Ig cross-reacts  with hamster Ig. 
1788  Natural Killer Cell Clones from p53-deficient  Mice Figure  3.  p53-deficient  clones express NKR-PI transcripts. Poly-A+ 
RNA (1-2 #g) from (lane I ) CTL-L, (lane  2) EL-4, (lane  3 ) KY-1, (lane 
4) KY-3, (lane  5) KY-4, and (lane  6) KY-2  cells  was subjected  to Northern 
blot analysis  with MusNKR-P1C cDNA. 
The  Cloned  Cell  Lines  Do  Not  Rearrange  TCR  Genes. 
Previous studies have shown that a subpopulation of CD3 + 
T cells express the NKI.1 antigen (44).  Moreover, cloned T 
cells can display NK-like (promiscuous) cytolytic activity even 
though the TCR may not be involved (45-47). The isolated 
clones did not express cell surface TCR/CD3 complex as de- 
termined by flow cytometry (Fig.  2 and data not shown), 
but it was possible that the TCR/CD3 complex was expressed 
at low levels or that its expression was downregulated during 
culture. To rule out the possibility that they belonged to the 
T  cell lineage, we analyzed the clones for TCR gene rear- 
rangement in comparison to two C57BL/6 T cell lines with 
TCR gene rearrangement as positive controls, and liver DNA 
and DNA isolated from Ly-49A- IL-2-activated NK cells as 
germline controls. 
Southern blot analysis with the TCR-oL probe revealed that 
restricted DNA  from  all  p53 -/-  clones  showed germline 
configuration (48) identical with liver DNA (Fig.  4 A). In 
contrast, a 3-kb band was deleted in DNA from CTL-L. When 
XbaI-digested liver DNA from C57BL/6 mice was hybrid- 
ized with TCR-3 probe, a characteristic germline pattern (45) 
was readily detectable in DNA from the p53-deficient clones 
(Fig. 4 B). Both T cell lines underwent productive rearrange- 
ment at the TCR-3  locus,  as evidenced by the appearance 
of novel bands in EL-4 (6 kb) and CTL-L (6.6  kb),  as well 
as deletion or alteration of a 2.8-kb fragment, respectively. 
Germline configuration (49)  for TCR-C3,1  was present in 
digested  DNA  from  NK  cell clones  and  C57BL/6  liver 
whereas EL-4 and CTL-L cells underwent C3'1 rearrangement 
displaying novel 25-kb bands and absence of 16- and 22-kb 
bands  (Fig.  4  C).  (CTL-L cells display lower intensity for 
the 16-kb band, suggesting rearrangement at only one locus, 
whereas EL4 appears  to have rearranged both loci. Neither 
effect is seen in the p53-deficient clones.) Similarly, the C~/4- 
specific probe detected germline fragments (50) in the clones 
(Fig. 4 D) and a rearranged "20-kb band in the T cell lines. 
The p53-deficient clones displayed germline configuration (51) 
for the ~ locus (Fig. 4 E), whereas in EL4 and CTL-L cells, 
the 2-kb fragment was deleted (more evident on longer ex- 
posures, not shown). CTL-L cells also deleted the 4-kb band. 
The TCtL-~ germline configuration in the clones is consis- 
tent with absence of  TCR-ot rearrangement because the TCR-~ 
locus is obligatorily deleted during VJcr rearrangement (48). 
These data demonstrate that the p53-deficient clones did not 
undergo productive gene rearrangement at any TCR locus. 
Moreover, Northern blot analysis using the same probes did 
not reveal full length transcripts for TCR genes (data not 
shown). Thus, the isolated p53-deficient clones are not T cells, 
and they possess  the molecular phenotype of NK cells. 
Clonal Differences in Target Cell Specificity.  All four clones 
e~ciently lysed the prototypical murine NK-sensitive target 
YAC-1 (Table 1). Although the lytic ability of the KY-1 clone 
was  slightly higher than  the activity of the other clones, 
significant  lysis  by  all  clones  was  always  detectable  for 
prolonged periods in continuous culture in IL-2 50 U/ml. 
Taken together with the absence of TCR gene rearrangement 
and TCR transcripts,  these functional data establish that these 
CD3- NKI.1 +  Fc3,RII/III +  p53-/-  cloned cell lines are NK 
cell clones. 
We investigated the ability of the NK cell clones to lyse 
other murine tumor targets (Table 1). Whereas the KY-1 clone 
was able  to lyse the C1498  (H-2  b)  target,  the other three 
clones repeatedly did not kill this tumor cell. Similarly, two 
other targets, L5178Y-R  (H-2  d) and BW5147  (H-2k), were 
killed efficiently by the KY-1 effectors but not by any of the 
other clones.  The R1.1  target  (H-2  k) can be killed by IL- 
2-activated NK cells (15), but it was ineffectively killed by 
the NK cell clones.  Other target cells were lysed by several 
clones, demonstrating that the KY-2, KY-3, and KY-4 clones 
effectively  recognize other targets in addition to YAC-1. The 
B16S melanoma and IC-21 cells (H-2  b) were killed by the 
KY-1 and KY-4 effectors.  The LB27.4  target  (H-2  d/b) was 
effectively lysed by the KY-1, KY-3,  and KY-4 clones. The 
P388D1  and WEHI  265  targets were equally killed by the 
KY-1 clone.  Yet,  P388D1  was killed by KY-3  clones,  and 
WEHI 265.1  was lysed by KY-2 but not by KY-3 effectors, 
even  though both  targets  are H-2  a macrophage cell lines. 
Therefore, these data demonstrate that the NK clones differ 
in their individual  specificity for various tumor targets. 
Target Cell MHC Class I Expression Does Not Influence Lysis 
by NK Cell Clones.  Target cell MHC class I expression in- 
versely correlates with susceptibility to NK cell lysis (8-15). 
Bulk NK cell populations from C57BL/6  mice spare  syn- 
geneic blasts  but  kill  blasts  from  32m -/-  mice  that  are 
deficient in cell surface MHC class I (52,  53). Although the 
KY-1 and KY-3 clones did not kill blasts from C57BL/6 mice, 
they also spared blasts  from ~2m -/-  mice (Table 2).  More- 
over, lysis of MHC class I-  mutant RMA-S cells was com- 
parable to parental RMA cells (H-2b),  and the 32m-  mu- 
tant  RIE/TLSx.1  and  parental  R1.1  (H-2  k)  cells  were 
1789  Karlhofer  et al. Figure 4.  p53-deficient  clones  did not rear- 
range TCR genes. 10/zg genomic  DNA from 
(lane 1  ) C57BL/6J  liver, (lane  2) Ly-49- IL-2- 
activated  NK cells, (lane  3) KY-1, (lane  4) KY-2, 
(lane 5) KY-3, (lane 6) KY-4, (lane 7) EL-4, 
or (lane  8) CTL-L  was digested  with XbaI (A 
and B)  or EcoRI (C-E), electrophoresed, 
blotted,  and  hybridized with  32p-labeled 
probes specific for TCR-ol (A), TCK-t8 (B), 
C3,1 (C), C2"4 (D), or TCR-t~  (E). Blots  were 
exposed to x-ray  films for 2 d to 3 wk. The 
blot shown  in B (TCR-~) was stripped and re- 
hybridized with the TClk-~ probe shown  in 
A. The blot shown in C (C3'1) was stripped 
and reprobed with the TCR-t~ probe shown 
in E. 
comparably resistant to lysis (Table 2). Finally, expression  of 
individual H-2  d class I  molecules (D  a,  K d,  and L  d)  trans- 
fected in C1498  (H-2  b) cells did not alter susceptibility to 
lysis by KY-1 effectors. Thus, these results suggest that target 
cell lysis by the NK clones is regulated by a mechanism that 
is independent of target cell MHC class I expression. 
Ly-49 Family Is Not Expressed  by NK Cell Clones.  Murine 
NK cells express inhibitory receptors  specific for MHC class 
I,  such as Ly-49A (15). None of these NK cell clones  ex- 
pressed Ly-49A, LGL-1, or 5E6 molecules by surface staining, 
even though bulk populations of NK cells from p53-/-  mice 
express these molecules on subpopulations similar to NK cells 
from p53  wt mice (data not shown).  Inasmuch as Ly-49A 
belongs to a family of molecules encoded by highly related 
genes, we performed Northern blot analysis using a Ly-49A 
cDNA. No cross-hybridizing transcripts were revealed in any 
of the NK clones under conditions that we have used to clone 
cDNAs for the new Ly-49 family members (Fig. 5; reference 
18). Thus,  the NK clones do not express Ly-49 molecules 
that could account for their specificity. 
Discussion 
Significant understanding of NK cell specificity has been 
provided by detailed analysis of human NK cell clones that 
display clonal variation in target cell specificity. Some inves- 
tigators have been able to define the MHC class I-associated 
specificity of human NK cell clones  on the basis of expres- 
sion of certain NK cell surface molecules (12-14).  In con- 
trast, other studies showed that many HLA alleles could confer 
resistance  to human NK cell clones and that a single  NK 
cell had the potential to recognize multiple distinct mole- 
cules (54).  In this analysis of >200 human NK cell clones, 
no overall pattern of MHC-dependent target cell resistance 
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Target  H-2  KY-1  KY-2  KY-3  KY-4 
A  YAC-1  a  65, 60,  -  42, 22,  9  39, 29, 26 
C1498  b  28,  12,-  0,  0,  0  0,  0,  2 
B  YAC-1  a  86, 77, 68  57, 41, 20 
L5178Y-R  d  51, 26, 21  11,  14,  7 
R1.1  k  11,  8,  4  10,  3,  3 
C  YAC-1  a  79, 59, 48  34, 28, 24 
BW5147  k  66, 51, 29  3,  4,  3 
LB27.4  d/b  85, 59, 34  39, 24,  18 
D  YAC-1  a  85, 80, 68  51, 40, 24 
L5178Y-R  d  75, 47, 32  4,  5,  4 
P388D1  d  91, 84, 51  38, 26, 19 
WEHI 265.1  d  98, 84, 32  2,  0,  6 
E  YAC-1  a  46, 38,  18 
WEHI 265.1  d  45, 33,  14 
F  YAC-1  a  77, 66, 41 
IC-21  b  57, 28,  5 
G  B16S  b  60, 50, 30 
IC-21  b  52, 36, 23 
31,  12,  -- 
0,  0,- 
37, 30,  3 
6,3,2 
25, 16,  10 
60, 64, 41 
27,  12,  3 
62, 57, 28 
26,  12,  4 
Lysis of indicated murine tumor target cells was determined at E/T cell ratios of 20:1, 6:1, 2:1. Individual  representative experiments are shown, 
separated by line breaks and indicated  by letters. Lysis  of YAC-1 target by NK clones  was routinely  included  in most experiments. The H-2 haplo- 
types of the targets are shown. Results are expressed as percentage of specific cytotoxicity  as averages of triplicate samples. 
emerged, and not all NK cells appeared  to be regulated by 
MHC class I molecules.  Perhaps this is caused by polymor- 
phism of relevant  genes (multiple genes with multiple al- 
leles) that may be variably expressed both by the NK cells 
and their targets. Currently, therefore, examination of the 
basis for human NK cell specificity may be difficult because 
of this marked complexity. 
Analysis of routine NK cell clones may circumvent some 
of these problems because of their derivation and availability 
of their targets from inbred genetic backgrounds. Moreover, 
the ability to  deliberately manipulate the mouse immune 
system and to target germline mutations may also help in 
dissection of mouse NK cell specificities and function. The 
definition of an inhibitory NK cell receptor, Ly-49A, at the 
molecular level is another current advantage to studying mouse 
NK cell clones. To date, Ly-49A is the only NK cell receptor 
that determines specificity in natural killing assays and whose 
primary structure and MHC class I ligand have been defined 
in functional and binding assays  (15-17, 35, 40). Recent studies 
on the SW5E6 and LGL-1 molecules, new members of the 
Ly-49 family, confirm the participation of these molecules 
in NK cell specificity  (20,  21). Although the lack of sero- 
logic reagents to detect all Ly-49 family members currently 
limits complete characterization of their cell surface expres- 
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sion, Ly-49-related transcripts are readily detectable in NK 
cells that do not express Ly-49A (18). Surprisingly, Ly-49- 
related transcripts were not detected in our mouse NK clones. 
It is not yet clear whether a population of NK cells, totally 
devoid of Ly-49 expression,  is normally present in vivo. Con- 
sistent with the hypothesis that the Ly-49 family is involved 
in MHC class I specificity of NK cells, we demonstrated that 
the lyric capacity of the murine clones was not regulated by 
target cell MHC class I expression.  Therefore, these clones 
permitted analysis of NK cell specificity that was indepen- 
dent of Ly-49 and MHC class I molecules. 
The murine NK cell clones  showed apparent differences 
in specificity because all clones were capable of lysing YAC-1 
cells, yet they had distinct variations in the ability to lyse 
other tumor targets. It is unlikely that any of the other pre- 
viously mentioned surface molecules that are associated with 
NK cell specificity could account for the specificity of the 
mouse clones. The human p58, Kp43, and NKB1 molecules 
appear to be NK cell receptors  with specificity for different 
HLA class I molecules (12-14).  Since we did not find any 
correlation between clone specificity and MHC haplotypes 
or MHC class I expression, however,  it appears  that none 
of the mouse homologues (not yet described) for these mole- 
cules are involved in the specificity of the mouse NK cell clones. Table 2.  MHC  Class 1-independent Lysis  by Mouse NK 
Cell Clones 
Target  KY-1  KY-3 
A  YAC-1  84,  78, 43  52, 56, 40 
B6 blasts  3,  14,  5  0,  0,  15 
fl2m -/-  blasts  4,  9,  1  0,  6,  7 
B  YAC-1  85, 84,  67  49, 39, 22 
RMA  28, 24,  6  2,  1,  1 
RMA-S  36,  28,  10  0,  0,  0 
C  YAC-1  72,  65,  51  51, 30,  10 
R.I.1  12,  5,  4  12,  5,  0 
RIE/TL8x.1  4,  2,  0  2,  1,  0 
D  YAC-1  89,  74,  58 
C1498  50, 34,  18 
C1498-D  a  65, 43,  32 
C1498-K  a  46, 25,  18 
C1498-L  a  54, 50, 37 
The lysis of MHC class I-transfected  C1498 (H-2b) cells, MHC class 
I-deficient mutant murine tumor targets, and Con  A blasts from 
C57BL/6J or B~n -/- mice  by the KY-1 and KY-3 NK clones was ana- 
lyzed as indicated in Table 1. Expression of the transfected  MHC class 
I on C1498 cells and absence of cell surface  MHC class I on the mutant 
cell lines RMA-S and RIE/TL8x.1 and blasts from/~2m  -/- mice was 
confirmed by flow cytometry. 
The CD2, CD16, CD69, and Ly-6 molecules have been im- 
plicated  in NK cell activation (2, 28).  None of these mole- 
cules are required for natural killing since natural killing may 
be performed by NK cells that lack their expression.  In addi- 
tion, the activation of antibody-dependent cellular cytotox- 
icity (ADCC) through the CD16 molecule induces tyrosine 
phosphorylation of its associated CD3~" chain (55).  Natural 
killing, however, does not involve this biochemical event, in- 
dicating that natural killing and ADCC use different prox- 
imal activation pathways (56). Moreover, these molecules are 
unlikely to be involved in the activation of the mouse NK 
cell clones because we could not stimulate cytotoxicity with 
mAbs directed against CD16, CD69, or Ly-6 (data not shown) 
under conditions that permit activation of IL-2-activated NK 
cells (27). 
Several other recently described NK cell surface molecules 
may play a role in natural killing. The mouse 2B4 molecule 
is expressed by all NK cells and a significant proportion of 
activated T cells (56). Anti-2B4 mAb stimulated lysis by NK 
and activated T  cells, suggesting that 2B4 may play a role 
in target cell lysis. However, 2B4 may not be involved in NK 
cell target specificity because it is expressed by all NK cells 
and does not display allelic polymorphism or belong to a family 
of related molecules (57). The human NK-TR1 molecule ap- 
pears to be involved in the activation pathway because  an- 
tisense  constructs against this molecule can inhibit natural 
Figure 5.  NK cell clones do not express Ly-49 transcripts. Poly-A  + 
RNA from (lane 1  ) CTbL, (lane  2) ED4, (lane  3) KY-1, (lane 4) KY-3, 
(lane 5) KY-4, and (lane 6) KY-2 cells was subjected to Northern blot 
analysis. Filters were probed with the PstI fragment  (639 bp) of the Ly- 
49A cDNA under  conditions  that detect  other  members  of  the Ly-49  family 
(18). The filter  was stripped and rehybridized  with a GAPD  probe  to dem- 
onstrate equal amounts  of RNA loaded  per lane (bottom). Similar  results 
were obtained  using a XhoI/Hind III 1,071-bp fragment  of the Ly-49A 
cDNA containing the full length  cDNA including  5' and 3' untranslated 
regions (not shown). Ly-49  transcripts  were not visible  on much  longer 
exposures (not shown). 
killing (58). The mouse NK2.1 molecule resembles the Ly- 
49A molecule because of its disulfide-linked structure, subset 
expression,  and  the  ability of F(ab')2 fragments  of anti- 
NK2.1 mAb to enhance killing of resistant targets (59).  It 
is  possible  that  these  molecules could contribute  to  the 
specificity of the mouse NK clones, but this will require fur- 
ther detailed analysis and availability of serologic reagents that 
block the function of these molecules. 
mAbs directed against NKR-P1 molecules stimulate NK 
cell cytolytic activity and biochemical signals seen in natural 
killing, suggesting that these rodent molecules  play an im- 
portant role in NK cell activation (28,  41, 42),  perhaps  as 
specific NK cell receptor molecules that bind target cell sur- 
face ligands.  However, we could not activate the mouse NK 
clones with an anti-NKl.1 mAb under conditions that stimu- 
late freshly isolated and IL-2-activated NK cells (28).  But 
mouse NKR-P1 molecules belong to a polymorphic family 
of at least three highly related molecules selectively expressed 
by NK cells, and the anti-NKl.1 mAb identifies  only one 
of these forms (36).  Although it cannot be ruled out that 
another NKR-P1 form may be involved in stimulating the 
mouse NK cell clones in natural killing, currently there are 
no available serologic reagents to analyze the other NKR-P1 
isoforms. 
Thus, the precise nature of the NK and target cell deter- 
minants responsible for Ly-49 and MHC class I-independent 
NK cell specificity have not been defined. Their identification 
will require development of new serologic  reagents such as 
1792  Natural  Killer Cell Clones from p53-deficient Mice mAbs, and ultimately molecular cloning. However, given the 
complexity of NK cell recognition, the availability  of mouse 
NK cell clones should prove useful in understanding NK cell 
recognition and specificity. 
Finally,  NK cells are frequently considered to be termi- 
nally differentiated cells. Certainly their ability to kill tumors 
and infected cells does not require proliferation or clonal ex- 
pansion. However, NK cells are not static participants in the 
immune response and proliferate in response to viral infec- 
tions (60). Moreover, marked expansion of NK cells occurs 
in vivo when mice are immunized with  Toxoplasma gondii 
(61), and normal murine NK cells vigorously proliferate in 
response to various stimuli in vitro (Karlhofer, F.  M.,  and 
W. M. Yokoyama, unpublished observation). Within ,x,10 d, 
however, they undergo a senescent process, for unclear reasons. 
The NK cell clones contained the homozygous p53-targeted 
mutation. Since we were not successful in obtaining NK cell 
clones from wild-type mice under similar conditions, long- 
term proliferation of the NK cell clones is likely to be attrib- 
utable to lack of functional p53, similar to growth character- 
istics of in vitro cultured p53-/-  fibroblasts (24). However, 
lack of p53 alone was not sufficient to confer immortality 
because the NK cell clones maintained a requirement for IL-2 
for proliferation, suggesting that they represent nontrans- 
formed NK clones.  These findings also are consistent with 
the known functions of p53 in cell cycle regulation. It can 
cause growth arrest in the G1 phase of the cell cycle, induces 
apoptosis under a variety of conditions (62), and plays a role 
in  survival  factor dependence of hematopoietic cells  (63). 
Regardless,  the derivation of cloned p53-/-  NK cell lines 
demonstrates a possible method to produce other murine cells 
that have been previously difficult to cultivate in vitro. Such 
nontransformed cells, including dendritic cells, Langerhans' 
cells,  and other primary APC,  thymocyte subsets,  thymic 
stromal cells, primary B cells, as well as neuronal and other 
end-organ cells,  and so on,  may similarly prove useful for 
studies of their respective functions. Strategies to induce tar- 
geted p53  mutations in primary human cells  also  may be 
rewarding. 
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